Site Search

... of these efforts, the House of Representatives of the State of Iowa issued a resolution designating March of each year as Precision Medicine and Biomarker Testing Awareness Month. Dubbed ‘the right treatment, to the right patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes. For example, patients with certain types of lung cancer who received biomarker testing had a 28% reduction in mortality. But in order to determine if a patient will benefit from certain targeted therapies, doctors ...

... Network (ACS CAN) volunteers from across Arizona rallied at the State Capitol Monday to urge lawmakers to pass legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better ...

... Network (ACS CAN) released new survey data today examining some of the most common barriers providers face in performing recommended cancer biomarker testing. The survey of 315 oncology providers found lab turnaround time was the greatest challenge to biomarker testing (41%), followed by patient concerns about out-of-pocket costs (39%) and insurance coverage of biomarker tests (37%). The majority ...

... that seek to promote Pennsylvanians’ ability to prevent, detect and survive cancer. Respectively, the proposals will improve access to biomarker testing (SB 954/HB 1754), establish a paid family and medical leave program (HB 181/SB 580) and reduce the toll of medical debt (HB 78). Volunteers met with lawmakers to discuss the power of biomarker testing to connect patients with the precision medicine treatments that have proven to reduce cancer patients’ risk of death and ...